Announcing a new article publication for BIO Integration journal. Cardiac cell death and myocardial fibrosis after ischemia-reperfusion (I/R) injury are the primary causes of impaired cardiac function ...
Agreement integrates Clyde Biosciences' human-relevant, CellOPTIQ cardiotoxicity screen for chemical safety assessment ...
While lower vertebrates can repair their adult hearts after a heart attack, mammals -- including humans -- cannot. The ability to regenerate dead muscle tissue in mammalian hearts disappears just a ...
This unexpected ability opens the door for scientists to stimulate cellular mitosis and improve heart function after an attack.
Developmental origin and subtype function of cardiac macrophages. Embryonic development (E7.5-E12.5) revolves around the hematopoietic endothelium (HE) of the yolk sac (YS), which undergoes three ...
TOKYO & PALO ALTO, Calif.--(BUSINESS WIRE)--Heartseed Inc. ("Heartseed"), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure and I Peace Inc. ("I Peace"), a ...
The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure. Researchers in the Michael E. DeBakey Department of Surgery at ...
In a recent review article published in the journal Microsystems & Nanoengineering, researchers explored the advancements in microfluidic technologies for monitoring the electromechanical activity of ...
University of Alabama at Birmingham researchers, led by Jianyi “Jay” Zhang, M.D., Ph.D., and Lei Ye, M.D., Ph.D., generated the human leukocyte antigen-knockout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results